Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases
- DOI
- 10.1021/acs.jmedchem.6c00667
- Published
- 2026-07-28
- Container
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c00667,
title = {Structure-Based
Drug Design of Novel Indazole/Indolinone-Based
Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory
Diseases},
author = {Zhenwei Zhang and Xue Wang and Xuan Luo and Cong Li and Zesheng Liu and Chunmei Xia and Leyi Yu and Xiaowei Chen and Yaqian Sun and Peipei Wang and Lixin Gao and Xinyue Cao and Yufei Zhang and Yibing Wang and Hong Liu and Yili Sun and Shengbin Zhou and Jia Li and Yu Zhou},
year = {2026},
journal = {Journal of Medicinal Chemistry},
doi = {10.1021/acs.jmedchem.6c00667},
url = {https://doi.org/10.1021/acs.jmedchem.6c00667}
}RIS
TY - JOUR TI - Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases AU - Zhenwei Zhang AU - Xue Wang AU - Xuan Luo AU - Cong Li AU - Zesheng Liu AU - Chunmei Xia AU - Leyi Yu AU - Xiaowei Chen AU - Yaqian Sun AU - Peipei Wang AU - Lixin Gao AU - Xinyue Cao AU - Yufei Zhang AU - Yibing Wang AU - Hong Liu AU - Yili Sun AU - Shengbin Zhou AU - Jia Li AU - Yu Zhou PY - 2026 JO - Journal of Medicinal Chemistry DO - 10.1021/acs.jmedchem.6c00667 UR - https://doi.org/10.1021/acs.jmedchem.6c00667 ER -
APA
Zhang, Z., Wang, X., Luo, X., Li, C., Liu, Z., Xia, C., Yu, L., Chen, X., Sun, Y., Wang, P., Gao, L., Cao, X., Zhang, Y., Wang, Y., Liu, H., Sun, Y., Zhou, S., Li, J., & Zhou, Y. (2026). Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00667
Source records
- crossref · retrieved 2026-09-26T06:12:28.802Z